Synlab, officially known as Synlab International GmbH, is a leading provider of laboratory services headquartered in Germany. Established in 2015, the company has rapidly expanded its operations across Europe, with a strong presence in countries such as France, Italy, and Spain. Specialising in medical diagnostics, environmental testing, and food safety, Synlab offers a comprehensive range of services that are distinguished by their commitment to quality and innovation. With a focus on advanced laboratory technology and a robust network of facilities, Synlab has positioned itself as a trusted partner in the healthcare and environmental sectors. The company has achieved significant milestones, including numerous accreditations and partnerships that enhance its market standing. By prioritising accuracy and efficiency, Synlab continues to set benchmarks in the laboratory services industry, making it a preferred choice for clients seeking reliable and timely results.
How does Synlab's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Synlab's score of 57 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, SYNLAB reported total carbon emissions of approximately 436,314,000 kg CO2e, with Scope 1 emissions at about 18,521,000 kg CO2e, Scope 2 emissions (market-based) at around 12,206,000 kg CO2e, and significant Scope 3 emissions totalling approximately 405,588,000 kg CO2e. The previous year, 2023, saw total emissions of about 442,173,000 kg CO2e, with Scope 1 at approximately 19,929,000 kg CO2e and Scope 2 (market-based) at about 11,527,000 kg CO2e. SYNLAB has committed to becoming carbon neutral by 2025, focusing on reducing operational emissions (Scope 1 and 2) and offsetting any remaining unavoidable emissions. This commitment is part of their broader strategy to enhance sustainability within the healthcare sector. The company aims to achieve these targets through continuous improvements in emissions intensity and operational efficiencies. The emissions data is sourced directly from SYNLAB AG, with no cascaded data from parent or related organizations. The company is actively working towards its climate goals, demonstrating a commitment to environmental responsibility in line with industry standards.
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 22,155,000  | 000,000,000  | 00,000,000  | 00,000,000  | 
| Scope 2 | 16,535,000  | 000,000,000  | 00,000,000  | 00,000,000  | 
| Scope 3 | -  | -  | 000,000,000  | 000,000,000  | 
Synlab's Scope 3 emissions, which decreased by 1% last year and decreased by approximately 1% since 2023, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 87% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Synlab has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Common questions about Synlab's sustainability data and climate commitments